...and Phase II testing for advanced polycythemia vera and essential thrombocythemia. Incyte retains rights to topical INCB18424...

...Phase II testing to treat advanced polycythemia vera and essential thrombocythemia. Incyte retained rights to topical INCB18424...

...a double-blind Phase IIb trial in 200 patients showed that all 3 doses of once-daily topical INCB18424...

...Buy Russo raised his target to $12 from $11 after all three doses of once-daily topical INCB18424...

...double-blind, U.S. trial enrolled 200 patients who received vehicle control or 0.5%, 1.0% or 1.5% topical INCB18424...

...Phase IIa trial (Study 201) in 28 patients showed that 1.0% once-daily and 1.5% twice-daily topical INCB18424...

...Data from an ongoing, 4-week Phase IIa trial in patients with mild-to-moderate psoriasis showed that topical INCB18424...

...In a placebo-controlled, dose-escalation Phase Ib/IIa trial in 18 patients with mild to moderate psoriasis, topical INCB18424...